ARTHROTEC® Principal Display Panel (misoprostol, diclofenac sodium)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Label

Arthrotec® 50

50 mg diclofenac sodium/
200 mcg misoprostol

Distributed by
G.D. Searle LLC
Division of Pfizer Inc, NY, NY 10017

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Label

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer

NDC 0025-1411-60

Arthrotec® 50
diclofenac sodium and misoprostol
delayed-release tablets

50 mg/200 mcg

DOSAGE AND USE
See accompanying prescribing information.

60 Tablets
Rx only

20688084

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 50 mg Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE
NDC 0025-1411-34
100 Tablets
UNIT DOSE

2146
MADE IN ENGLAND

Arthrotec® 50
50 mg diclofenac sodium/
200 mcg misoprostol

50 mg/200 mcg

11004701

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Label

Arthrotec® 75

75 mg diclofenac sodium/
200 mcg misoprostol

Distributed by
G.D. Searle LLC
Division of Pfizer Inc, NY, NY 10017

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Label

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer

NDC 0025-1421-60

Arthrotec® 75
diclofenac sodium and misoprostol
delayed-release tablets

75 mg/200 mcg

DOSAGE AND USE
See accompanying prescribing information.

60 Tablets
Rx only

20688086

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 75 mg Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE
NDC 0025-1421-34
100 Tablets
UNIT DOSE

2149
MADE IN ENGLAND

Arthrotec® 75
75 mg diclofenac sodium/
200 mcg misoprostol

75 mg/200 mcg

11004901

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ARTHROTEC® Quick Finder

Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All